𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical implication of screeningp53gene mutations in head and neck squamous cell carcinomas

✍ Scribed by L. Ma; A. Ronai; U. N. Riede; G. Köhler

Publisher
Springer-Verlag
Year
1998
Tongue
English
Weight
186 KB
Volume
124
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of gene amplification in head-a
Analysis of gene amplification in head-and-neck squamous-cell carcinomas
✍ J. Helen Leonard; John H. Kearsley; Georgia Chenevix-Trench; Nicholas K. Hayward 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 656 KB

The presence of gene amplification was determined in 66 fresh head-and-neck SCC specimens using a battery of 9 different probes. Amplification of at least one gene was found in I 2 samples (18%), of which 7 were amplified at multiple loci (58%). We observed amplifications for EGFR (10% of samples) a

Mutational analysis of the PTEN gene in
Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma
✍ Xiyun Shao; Raj Tandon; Ghassan Samara; Hiroaki Kanki; Hiroko Yano; Lanny G. Clo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB 👁 2 views

## Loss of heterozygosity (LOH ) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carci

Gene expression profiling in head and ne
Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives
✍ Benjamin Lallemant; Alexandre Evrard; Guillaume Chambon; Omar Sabra; Sophie Kach 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Abstract ## __Background.__ To date, more than 60 gene expression profiling (GEP) studies have been published in the field of head and neck squamous cell carcinoma (HNSCC) with variable objectives, methods, and results. ## __Methods.__ The purpose of this study was to present a state‐of‐the‐a

P53 mutation correlates with cisplatin s
P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines
✍ Carol R. Bradford; Shaobo Zhu; Haruko Ogawa; Tetsuya Ogawa; Matthew Ubell; Ajita 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did